SCHEMBL29474159

SCHEMBL29474159

CC(C)c1c(F)cc2c(cnn2C2CCCCO2)c1Br

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 2/20 0.40
▸ CYP4A11 Q02928 2/20 0.40
▸ RXRA P19793 1/20 0.38
▸ RXRB P28702 1/20 0.38
▸ RXRG P48443 1/20 0.38
▸ KDM5B Q9UGL1 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ RET P07949 5/20 0.35
▸ KDM5A P29375 1/20 0.33
▸ ATR Q13535 7/20 0.32
▸ PDE1A P54750 1/20 0.31
▸ PDE1B Q01064 1/20 0.31
▸ PDE1C Q14123 1/20 0.31
▸ ESR1 P03372 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28954110 1.00 CYP4F2 (0.40) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL26121450 0.90 CYP4F2 (0.41) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL30556578 0.90 CYP4F2 (0.41) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL30959175 0.87 RXRA (0.39) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL21379219 0.85 CYP4F2 (0.45) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL29593100 0.85 CYP4F2 (0.45) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL24274351 0.82 LMNA (0.43) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL21195912 0.82 CYP4F2 (0.42) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL29474190 0.82 CYP4F2 (0.42) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL29385882 0.82 CYP4F2 (0.42) CYP4F2CYP4A11RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4217358-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS OF USING SAME 1st Biotherapeutics, Inc. (KR) 2023-08-02 — — EP disclosed
CN-114599651-A Indazoles as inhibitors of hematopoietic progenitor kinase 1(HPK1) and methods of use thereof 第一生物治疗股份有限公司 2022-06-07 — — CN disclosed
CN-114599653-A Indazoles as inhibitors of hematopoietic progenitor kinase 1(HPK1) and methods of use thereof 第一生物治疗股份有限公司 2022-06-07 — — CN disclosed
WO-2022064459-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS OF USING SAME 1ST Biotherapeutics, Inc. (KR) 2022-03-31 — — WO disclosed
WO-2022064458-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS OF USING SAME 1ST Biotherapeutics, Inc. (KR) 2022-03-31 — — WO disclosed
Send feedback